Recent literature demonstrates the role of CXCR2 ligands in cancer and metastasis, such as CXCL6, one of the CXCR2 ligands that contributes to osteoclast differentiation and activation in a RANKL-dependent pathway [24]. This evidence concerns the gene CXCR2 and cancer.